Compare the different types of disease modifying drugs (DMDs) that are available to treat multiple sclerosis (MS).

Dysarthria is a speech disorder that can occur in multiple sclerosis. It is caused by weakness or lack of coordination in the muscles used in speaking.

Orelabrutinib is a Bruton's tyrosine kinase inhibitor (BTKi) being tested as a new treatment for relapsing remitting multiple sclerosis (MS).

Erectile dysfunction in MS can be treated with these medications. Talk to your GP or MS team to get help.

Respite care is short-term, temporary support that allows people with multiple sclerosis (MS), and the family members or carers who look after them, to have a break and a little time to themselves.

Deep brain stimulation is an invasive surgical technique sometimes used to treat serious tremor in multiple sclerosis (MS).

The NHS in England recently presented an algorithm for the treatment options in MS. This describes the criteria where each licenced disease modifying drug (DMD) could be prescribed, depending on the type of MS you have and how it has responded to treatment.

The Cari Loder regime was a proposed treatment for multiple sclerosis (MS) that attracted some media attention during the 1990s

Which contraceptive methods are suitable in MS?